The GOODFOOTEX committeeis formed by three companies that cover the entire textile value chain, from the spinning process (DEFIBER) through weaving, finishing and clothing (ARETEX-CONDOR, PUNTO BLANCO), and has the support of the Textile Technology Center of Research FITEX.
Three lines of research have been established that include both the study of materials and the industrial processes in which they should be incorporated. This will involve both research work in the manufacture of the yarn that should make the garments and in the actual weaving or finishing stage:
ADDITIVES IN SYNTHETIC FIBERS:
New mixtures and additives of materials for the manufacture of synthetic,recycled and/or natural fiber yarn with smart therapeutic and cosmetic properties.
STUDY OF PRESSURE IN WEAVING PRODUCTS:
Optimization and control of the weaving process to maximize the ergonomic and therapeutic comfort of the garments by controlling the pressure.
New processes ofnatural and environmentally friendly dyeing, printing and finishing to incorporate and/or improve smart therapeutic and cosmetic properties.
It is expected that companies can obtain a wide range of products with four basic requirements applied specifically for each pathology to be treated; they are:
From the research on high hydration of some products to those that will avoid/reduce the excess of water or sweat generated by the body.
Not all patients with diabetes or arterial ischemia need low/high pressure of the garment, this is why we seek to expand the range of products so that the diabetic/ischemic/dry foot patient can find the product that really meets the needs and morphology thanks to new materials and the proper ergonomic study of the garments.
A proper study of materials and weaving systems will enable us to provide adequate breathability without reducing the pressure and, therefore, the associated therapeutic treatment.
One of the aspects in which the committee seeks to make a difference from the other existing products on the market is applying the concept fashion and comfort to the therapeutic products discussed here. In order to have a better integration and quality of life of the consumers of these garments, we will not manufacture “medical-type” products where design and comfort are not taken into account.